Biomarker for Rheumatic Heart Disease (RHD)- Prototype is Ready for Commercialization
Implementing Organization
Indian Institute of Chemical Biology (IICB)
Project Overview
It is a protein based biomarker, it is detected in serum and urine, This test kit would help measurement of clinical activity in quiescent rheumatic heart disease, post penicillin treatment and overall management of the disease.
Benefits
Measrement of clinical activityin RHD, prognosis and overall management of rhheumatic heart disease.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Indian Institute of Chemical Biology (IICB)
Accessibility Controls